Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.36 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.34 |
| ▸ | HPRT1 | P00492 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17471799 | 1.00 | SIGMAR1 (0.39) | SIGMAR1ESR1ESR2HSD17B1HSD17B2 | |
| SCHEMBL17970832 | 1.00 | SIGMAR1 (0.39) | SIGMAR1ESR1ESR2HSD17B1HSD17B2 | |
| SCHEMBL29512089 | 1.00 | SIGMAR1 (0.39) | SIGMAR1ESR1ESR2HSD17B1HSD17B2 | |
| SCHEMBL18069058 | 1.00 | SIGMAR1 (0.39) | SIGMAR1ESR1ESR2HSD17B1HSD17B2 | |
| SCHEMBL18069057 | 0.98 | SIGMAR1 (0.38) | SIGMAR1ESR1ESR2HSD17B1HSD17B2 | |
| SCHEMBL17125612 | 0.98 | SIGMAR1 (0.38) | SIGMAR1ESR1ESR2HSD17B1HSD17B2 | |
| SCHEMBL7090579 | 0.98 | SIGMAR1 (0.38) | SIGMAR1ESR1ESR2HSD17B1HSD17B2 | |
| SCHEMBL10136036 | 0.98 | SIGMAR1 (0.38) | SIGMAR1ESR1ESR2HSD17B1HSD17B2 | |
| SCHEMBL14111970 | 0.98 | SIGMAR1 (0.38) | SIGMAR1ESR1ESR2HSD17B1HSD17B2 | |
| SCHEMBL14520007 | 0.98 | SIGMAR1 (0.38) | SIGMAR1ESR1ESR2HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1437 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10573836-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-02-25 | — | — | US | claimed |
| US-20180159061-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-06-07 | — | — | US | claimed |
| US-9865833-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-09 | — | — | US | claimed |
| US-20150115231-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-04-30 | — | — | US | claimed |
| US-20150097167-A1 | ORGANIC LIGHT EMITTING DEVICE AND ORGANIC LIGHT EMITTING DISPLAY HAVING THE SAME | LG DISPLAY CO., LTD. (KR) | 2015-04-09 | — | — | US | claimed |
| EP-2286474-A2 | METHOD OF MAKING AN OLED | Merck Patent GmbH (DE) | 2011-02-23 | — | — | EP | claimed |
| US-7767316-B2 | Organic electroluminescent devices and composition | GLOBAL OLED TECHNOLOGY LLC (US) | 2010-08-03 | — | — | US | claimed |
| WO-2009149860-A2 | METHOD OF MAKING AN OLED | MERCK PATENT GMBH (DE) | 2009-12-17 | — | — | WO | claimed |
| US-7579090-B2 | Organic element for electroluminescent devices | EASTMAN KODAK COMPANY (US) | 2009-08-25 | — | — | US | claimed |
| US-7504163-B2 | Hole-trapping materials for improved OLED efficiency | EASTMAN KODAK COMPANY (US) | 2009-03-17 | — | — | US | claimed |
| US-6967062-B2 | White light-emitting OLED device having a blue light-emitting layer doped with an electron-transporting or a hole-transporting material or both | EASTMAN KODAK COMPANY (US) | 2005-11-22 | — | — | US | claimed |
| US-6919140-B2 | Organic electroluminescent devices with high luminance | EASTMAN KODAK COMPANY (US) | 2005-07-19 | — | — | US | claimed |
| US-20050106415-A1 | Aggregate organic light emitting diode devices with improved operational stability | EASTMAN KODAK COMPANY | 2005-05-19 | — | — | US | claimed |
| WO-2005042668-A1 | ELECTROLUMINESCENT DEVICE WITH ANTHRACENE DERIVATIVE HOST | EASTMAN KODAK COMPANY (US) | 2005-05-12 | — | — | WO | claimed |
| US-20050089717-A1 | Electroluminescent device with anthracene derivative host | EASTMAN KODAK COMPANY | 2005-04-28 | — | — | US | claimed |
| US-6849345-B2 | Organic electroluminescent devices with high luminance | EASTMAN KODAK COMPANY (US) | 2005-02-01 | — | — | US | claimed |
| US-20050014018-A1 | Organic electroluminescent devices with high luminance | EASTMAN KODAK COMPANY | 2005-01-20 | — | — | US | claimed |
| US-20040185300-A1 | White light-emitting OLED device having a blue light-emitting layer doped with an electron-transporting or a hole-transporting material or both | EASTMAN KODAK COMPANY | 2004-09-23 | — | — | US | claimed |
| US-20040076853-A1 | Organic light-emitting diode devices with improved operational stability | EASTMAN KODAK COMPANY | 2004-04-22 | — | — | US | claimed |
| US-20030129449-A1 | Organic electroluminescent devices with high luminance | EASTMAN KODAK COMPANY | 2003-07-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030129449-A1 | Organic electroluminescent devices with high luminance | ARL1, ALDH1A2, EML4 | SIGMAR1 3319/4885ESR1 45/4885ESR2 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.